| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/17/2003 | US20030134839 5-(Alkylidene-cycloalkyl)-and 5-(alkylidene-heterocyclyl)-pyrazoles |
| 07/17/2003 | US20030134836 Substituted arylamine derivatives and methods of use |
| 07/17/2003 | US20030134829 X is a ring having at least 4 atoms in the ring; K is hydrocarbyl group; Rh1 is an optional halo group; Rh2 is an optional halo group; at least one of Rh1 and Rh2 is present; Rs is any one of a sulphamate group, a phosphonate, |
| 07/17/2003 | US20030134810 Delivery of pharmacologically active agents associated with polymeric biocompatible materials. Compositions comprising a first, negatively charged pharmacologically active agent such as an oligonucleotide and a polycationic polymer such as |
| 07/17/2003 | US20030134804 Rehydrating formulation |
| 07/17/2003 | US20030134430 Novel amino acid sequences for human caenorhabditis elegans-like protein polypeptides |
| 07/17/2003 | US20030133998 Comprising diphenhydramine HCl, belladonna tincture, buffer, flavourants, absolute alcohol, wherein alcohol concentrate comprises 2.8%-3.2% by volume |
| 07/17/2003 | US20030133988 Immunomodulation accomplished by administration of immunomodulatory polynucleotide/microcarrier complexes comprising 3-6 mer immunomodulatory oligonucleotides |
| 07/17/2003 | US20030133985 Controlled release oral dosage forms; data obtained using disintegration test such as the established USP Disintegration Test, rather than the results obtained using a standard USP Dissolution Test, as is conventionally done |
| 07/17/2003 | US20030133983 Comprises core and enteric coating, the core including, as a pharmaceutical active compound, aminosalicylic acid or a derivative thereof; treatment of ulcerative colitis and Crohn's disease |
| 07/17/2003 | US20030133930 Administering to a patient having an autoimmune disorder an antibody to a B-cell antigens and a carrier; CD22, CD20, CD19, and CD74 or HLA-DR antigen. |
| 07/17/2003 | US20030133929 Draining blood from the animal, separating blood cells from plasma, contacting plasma with a solvent in which lipids are soluble, separating plasma to reintroduce it into the animal, separating dissolved lipids |
| 07/17/2003 | US20030133913 Producing chemokine receptors, inducing antigen by dendritic cells in vitro, for therapeutic or prophylactic purposes |
| 07/17/2003 | US20030133880 Powdery pharmaceutical compositions for inhalation |
| 07/17/2003 | US20030133875 Assay for screening candidate drug for the treatment of inflammatory diseases and methods for treating the same |
| 07/17/2003 | CA2472585A1 Drug mixture with enhanced dissolution rate |
| 07/17/2003 | CA2472165A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
| 07/17/2003 | CA2472111A1 Human mast cell-expressed membrane proteins |
| 07/17/2003 | CA2472049A1 Dominant negative proteins and methods thereof |
| 07/17/2003 | CA2471957A1 Cyclic tetrapeptide compound and use thereof |
| 07/17/2003 | CA2471951A1 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
| 07/17/2003 | CA2471566A1 Combination of mtp inhibitors or apob-secretion inhibitors with fibrates for use as pharmaceuticals |
| 07/17/2003 | CA2471504A1 Ligand for g-protein coupled receptor gpr43 and uses thereof |
| 07/17/2003 | CA2471490A1 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
| 07/17/2003 | CA2471204A1 Inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | CA2469480A1 Use of biomolecular targets in the treatment and visualization of tumors |
| 07/17/2003 | CA2469162A1 Composition inhibiting matrix-metallproteinases for the treatmentof neoplastic diseases |
| 07/17/2003 | CA2469052A1 Transdifferentiation of pancreatic acinar cells |
| 07/17/2003 | CA2468700A1 Extended glucagon-like peptide-1 analogs |
| 07/16/2003 | EP1327448A1 Homeostasis-maintaining agents |
| 07/16/2003 | EP1326971A2 Proteins and nucleic acids encoding same |
| 07/16/2003 | EP1326896A2 Human anti-cd40 antibodies |
| 07/16/2003 | EP1326869A1 Pyrrole-condensed morphinoid derivatives |
| 07/16/2003 | EP1326868A1 Morphinoid derivatives as delta-opioid agonists and antagonists |
| 07/16/2003 | EP1326867A2 Bridged piperazine derivatives |
| 07/16/2003 | EP1326866A1 Substituted 3.4-dihydro-pyrido[1,2-a]pyrimidines |
| 07/16/2003 | EP1326864A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 07/16/2003 | EP1326863A2 Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines |
| 07/16/2003 | EP1326861A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
| 07/16/2003 | EP1326859A1 Quinazoline derivatives with anti-tumour activity |
| 07/16/2003 | EP1326858A2 Piperidine compounds as anti-allergic |
| 07/16/2003 | EP1326856A1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity |
| 07/16/2003 | EP1326835A1 Benzamide compounds as apo b secretion inhibitors |
| 07/16/2003 | EP1326828A1 Beta-amino acid derivatives as integrin receptor antagonists |
| 07/16/2003 | EP1326826A1 Use of amino acids for treating pain |
| 07/16/2003 | EP1326822A2 Ketone compounds and compositions for cholesterol management and related uses |
| 07/16/2003 | EP1326643A2 Inhibition of emetic effect of metformin with 5-ht3 receptor antagonists |
| 07/16/2003 | EP1326642A2 Catecholamine pharmaceutical compositions and methods |
| 07/16/2003 | EP1326632A2 Agents for the treatment of viral infections |
| 07/16/2003 | EP1326630A2 Use of glp-1 and glp-2 peptides |
| 07/16/2003 | EP1326619A2 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 07/16/2003 | EP1326618A2 Use of aryl-substituted 1,1-diphosphonates for the treatment of bone diseases |
| 07/16/2003 | EP1326606A2 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 07/16/2003 | EP1326599A2 Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin |
| 07/16/2003 | EP1326594A2 Ribavirin-pegylated interferon alfa hcv combination therapy |
| 07/16/2003 | EP1326592A1 Use of polyethylene glycol ( peg ) for the manufacture of a medicament for the treatment of constipation |
| 07/16/2003 | EP1326589A2 Nanoparticles |
| 07/16/2003 | EP1326583A1 Medication delivery devices |
| 07/16/2003 | EP1181284B1 Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use |
| 07/16/2003 | EP1155000B1 2-aminopyridines containing fused ring substituents |
| 07/16/2003 | EP1084104B1 Nitric oxide synthase inhibitors |
| 07/16/2003 | EP1070069B1 Bicyclic hydroxamic acid derivatives |
| 07/16/2003 | EP1017385B1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1 |
| 07/16/2003 | EP0852586B1 Use of a 24 kDa protein for treating and diagnosing an HCV Infektion |
| 07/16/2003 | EP0832076B1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 07/16/2003 | EP0550550B1 3,9-diazabicyclo (3.3.1) nonan-7-yl derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them |
| 07/16/2003 | CN1430620A Macrolides compound |
| 07/16/2003 | CN1430611A 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists |
| 07/16/2003 | CN1430610A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 07/16/2003 | CN1430609A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 07/16/2003 | CN1430607A Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 07/16/2003 | CN1430603A Novel bicyclic compounds |
| 07/16/2003 | CN1430602A Ary-and heteroaryl sulfonates compounds |
| 07/16/2003 | CN1430597A Novel MMP-2/MMP-9 inhibitors |
| 07/16/2003 | CN1430519A Combinations of enzyme inhibitor-containing preparations and the use thereof |
| 07/16/2003 | CN1430517A Pepsin inhabition by alginates |
| 07/16/2003 | CN1430512A Modulation of bone formation |
| 07/16/2003 | CN1429908A Gene modification sequence of gene recombination hepatitis virus surface antigen and its product |
| 07/16/2003 | CN1429842A Deer serum active polypeptide crystal preparation and its preparing method |
| 07/16/2003 | CN1429836A Hepatitis C virus high change region 1 synthetic peptide and its use |
| 07/16/2003 | CN1429832A Nucleotide specific to O-antigen of shigella boydii 7 |
| 07/16/2003 | CN1429625A Medicine for treating chronic hepatitis B |
| 07/16/2003 | CN1429621A Edible fungus formula for treating hepatitis disease and its preparation method |
| 07/16/2003 | CN1429620A Health care capsule for middle aged woman |
| 07/16/2003 | CN1429613A Colonitis enteroclysm |
| 07/16/2003 | CN1429607A Red sage root-astragalus root particles for liver softening |
| 07/16/2003 | CN1429603A Medicine for treating stomach disease |
| 07/16/2003 | CN1429601A Heat-Clearing away heat and toxic material and subsidence of swelling powder |
| 07/16/2003 | CN1429600A Medicine for treating intestinal disease |
| 07/16/2003 | CN1429597A Medicine for growing and firming tooth and its preparation method |
| 07/16/2003 | CN1429592A Liver softening spleen reducing capsule |
| 07/16/2003 | CN1429591A Fat reducing liver protecting capsule |
| 07/16/2003 | CN1429590A Transaminase lowering capsule |
| 07/16/2003 | CN1429586A Medicine for treating cholecithes and its preparation method |
| 07/16/2003 | CN1429584A Distillate for antiemetic |
| 07/16/2003 | CN1429582A Fulonggan mixture for treating vomiting of pregnancy |
| 07/16/2003 | CN1429575A Normalizing function of gallbladder and removal of gallstones capsule |
| 07/16/2003 | CN1429574A Capsule for treating hepatitis B |
| 07/16/2003 | CN1429556A Muscle strong agent and anti-inflammatory agent |
| 07/16/2003 | CN1429555A Adfuwei ester soft capsule and its preparation method |